Page 168 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 168

154     SECTION II  Autonomic Drugs


                  SUMMARY  Sympathomimetic Drugs


                                                                                            Pharmacokinetics, Toxicities,
                  Subclass, Drug  Mechanism of Action  Effects           Clinical Applications  Interactions
                  ` 1  AGONISTS                                                              
                    •  Midodrine  Activates phospholipase C,   Vascular smooth muscle   Orthostatic hypotension  Oral • prodrug converted to active drug
                                resulting in increased   contraction increasing blood       with a 1-h peak effect • Toxicity: Supine
                                intracellular calcium and   pressure (BP)                   hypertension, piloerection (goose bumps),
                                vasoconstriction                                            and urinary retention

                    •  Phenylephrine: Can be used IV for short-term maintenance of BP in acute hypotension and intranasally to produce local vasoconstriction as a decongestant
                  ` 2  AGONISTS                                                              
                    •  Clonidine  Inhibits adenylyl cyclase    Vasoconstriction is masked   Hypertension  Oral • transdermal • peak effect 1–3 h • t 1/2
                                and interacts with other   by central sympatholytic         of oral drug ~12 h • produces dry mouth
                                intracellular pathways  effect, which lowers BP             and sedation
                    •  α-Methyldopa, guanfacine, and guanabenz: Also used as central sympatholytics
                    •  Dexmedetomidine: Prominent sedative effects and used in anesthesia
                    •  Tizanidine: Used as a muscle relaxant
                    •  Apraclonidine and brimonidine: Used topically in glaucoma to reduce intraocular pressure
                  a 1  AGONISTS                                                              
                    •  Dobutamine 1  Activates adenylyl cyclase,   Positive inotropic effect  Cardiogenic shock, acute   IV • requires dose titration to desired effect
                                increasing myocardial                    heart failure
                                contractility
                  a 2  AGONISTS                                                              
                    •  Albuterol  Activates adenylyl cyclase  Bronchial smooth muscle   Asthma  Inhalation • duration 4–6 h • Toxicity:
                                                     dilation                               Tremor, tachycardia
                    •  See other β 2  agonists in Chapter 20
                  a 3  AGONISTS                                                              
                    •  Mirabegron  Activates adenylyl cyclase  Reduces bladder tone  Urinary urgency  Oral • duration 50 h • Toxicity: Possible
                                                                                            hypertension
                  DOPAMINE AGONISTS

                  D 1  Agonists                                                              
                    •  Fenoldopam  Activates adenylyl cyclase  Vascular smooth muscle   Hypertensive emergency  Requires dose titration to desired effect
                                                     relaxation

                  D 2  Agonists                                                              
                    •  Bromocriptine  Inhibits adenylyl cyclase    Mimics dopamine actions    Parkinson’s disease,   Oral • Toxicity: Nausea, headache,
                                and interacts with other   in the CNS    prolactinemia      orthostatic hypotension
                                intracellular pathways
                    •  See other D 2  agonists in Chapters 28 and 37
                 1
                 Dobutamine has other actions in addition to β 1 -agonist effect. See text for details.
   163   164   165   166   167   168   169   170   171   172   173